Galectin Therapeutics
GALT
#8074
Rank
โ‚น14.36 B
Marketcap
โ‚น230.71
Share price
1.48%
Change (1 day)
44.71%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น9.21 B

According to Galectin Therapeutics's latest financial reports the company's total liabilities are โ‚น9.21 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น4.42 B51.44%
2021-12-31โ‚น2.92 B640.2%
2020-12-31โ‚น0.39 B93.11%
2019-12-31โ‚น0.20 B39.42%
2018-12-31โ‚น0.14 B-22.63%
2017-12-31โ‚น0.18 B-26.22%
2016-12-31โ‚น0.25 B184.25%
2015-12-31โ‚น90.36 M-16.15%
2014-12-31โ‚น0.10 B-29.85%
2013-12-31โ‚น0.15 B70.66%
2012-12-31โ‚น90.02 M-23.17%
2011-12-31โ‚น0.11 B-67.3%
2010-12-31โ‚น0.35 B56.92%
2009-12-31โ‚น0.22 B291.66%
2008-12-31โ‚น58.31 M-68.58%
2007-12-31โ‚น0.18 B-34.38%
2006-12-31โ‚น0.28 B355.38%
2005-12-31โ‚น62.1 M57.11%
2004-12-31โ‚น39.52 M129.24%
2003-12-31โ‚น17.24 M-46.08%
2002-12-31โ‚น31.97 M20.34%
2001-12-31โ‚น26.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น15.37 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น56.17 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA